Oncotarget Identifying Biomarkers for Predicting Paclitaxel Response In this research perspective, researchers discuss causal and correlative approaches to identify potential biomarkers for... read more March 28, 2024
Oncotarget New Drug May Boost Effectiveness of Glioblastoma Treatment In a new study, researchers investigated the activity of gartisertib, a potent ATR inhibitor, alone... read more January 25, 2024
Oncotarget Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer In a new editorial, researchers discuss opening the blood-brain barrier and a promising new strategy... read more May 11, 2023
Oncotarget Behind the Study: Extending Survival in Glioma Models Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more May 10, 2021
Oncotarget New Analogs of Mibefradil Created as Radiosensitizers for Glioblastoma Researchers from Yale University conducted a study to create mibefradil analogs as superior radiosensitizers in... read more April 28, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #9 Read short summaries of the latest research published by Oncotarget.Origin: Connecticut, ... read more April 27, 2021
Oncotarget Behind the Study: Statins Primary Mode of Action Against Cancer Cells Neuro-oncologist physician-scientist Dr. Benjamin Purow describes the findings in a paper he helped author in... read more February 15, 2021